These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 36537421)

  • 1. Role of Multivoxel MR Spectroscopy Progressive Supranuclear Palsy - A Preliminary Study.
    Mangalore S; Kumar M; Pal P; Saini J; Pasha S; Yadav R
    Neurol India; 2022; 70(6):2388-2391. PubMed ID: 36537421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo evidence for decreased scyllo-inositol levels in the supplementary motor area of patients with Progressive Supranuclear Palsy: A proton MR spectroscopy study.
    Barbagallo G; Morelli M; Quattrone A; Chiriaco C; Vaccaro MG; Gullà D; Rocca F; Caracciolo M; Novellino F; Sarica A; Arabia G; Sabatini U; Quattrone A
    Parkinsonism Relat Disord; 2019 May; 62():185-191. PubMed ID: 30558837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative magnetic resonance spectroscopic imaging in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Guevara CA; Blain CR; Stahl D; Lythgoe DJ; Leigh PN; Barker GJ
    Eur J Neurol; 2010 Sep; 17(9):1193-1202. PubMed ID: 20402762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging in progressive supranuclear palsy.
    Stamelou M; Knake S; Oertel WH; Höglinger GU
    J Neurol; 2011 Apr; 258(4):549-58. PubMed ID: 21181185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology.
    Whitwell JL; Jack CR; Parisi JE; Gunter JL; Weigand SD; Boeve BF; Ahlskog JE; Petersen RC; Dickson DW; Josephs KA
    Eur J Neurol; 2013 Oct; 20(10):1417-22. PubMed ID: 23746093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The contribution of cerebellar proton magnetic resonance spectroscopy in the differential diagnosis among parkinsonian syndromes.
    Zanigni S; Testa C; Calandra-Buonaura G; Sambati L; Guarino M; Gabellini A; Evangelisti S; Cortelli P; Lodi R; Tonon C
    Parkinsonism Relat Disord; 2015 Aug; 21(8):929-37. PubMed ID: 26077167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome.
    Williams DR; Holton JL; Strand C; Pittman A; de Silva R; Lees AJ; Revesz T
    Brain; 2007 Jun; 130(Pt 6):1566-76. PubMed ID: 17525140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy.
    Borroni B; Malinverno M; Gardoni F; Alberici A; Parnetti L; Premi E; Bonuccelli U; Grassi M; Perani D; Calabresi P; Di Luca M; Padovani A
    Neurology; 2008 Nov; 71(22):1796-803. PubMed ID: 18971445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of proton magnetic resonance spectroscopy in differentiating parkinsonian syndromes.
    Federico F; Simone IL; Lucivero V; Mezzapesa DM; de Mari M; Lamberti P; Petruzzellis M; Ferrari E
    Ital J Neurol Sci; 1999 Aug; 20(4):223-9. PubMed ID: 10551908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity and sensitivity of magnetic resonance imaging findings in the diagnosis of progressive supranuclear palsy.
    Bacchi S; Chim I; Patel S
    J Med Imaging Radiat Oncol; 2018 Feb; 62(1):21-31. PubMed ID: 28432758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation.
    Stejskalova Z; Rohan Z; Rusina R; Tesar A; Kukal J; Kovacs GG; Bartos A; Matej R
    BMC Neurol; 2019 Mar; 19(1):42. PubMed ID: 30894142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The midbrain-to-pons ratio distinguishes progressive supranuclear palsy from non-fluent primary progressive aphasias.
    Silsby M; Tweedie-Cullen RY; Murray CR; Halliday GM; Hodges JR; Burrell JR
    Eur J Neurol; 2017 Jul; 24(7):956-965. PubMed ID: 28510312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.
    Williams DR; de Silva R; Paviour DC; Pittman A; Watt HC; Kilford L; Holton JL; Revesz T; Lees AJ
    Brain; 2005 Jun; 128(Pt 6):1247-58. PubMed ID: 15788542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration.
    Gröschel K; Hauser TK; Luft A; Patronas N; Dichgans J; Litvan I; Schulz JB
    Neuroimage; 2004 Feb; 21(2):714-24. PubMed ID: 14980574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy.
    Ali F; Martin PR; Botha H; Ahlskog JE; Bower JH; Masumoto JY; Maraganore D; Hassan A; Eggers S; Boeve BF; Knopman DS; Drubach D; Petersen RC; Dunkley ED; van Gerpen J; Uitti R; Whitwell JL; Dickson DW; Josephs KA
    Mov Disord; 2019 Aug; 34(8):1144-1153. PubMed ID: 30726566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic Resonance Parkinsonism Index: diagnostic accuracy of a fully automated algorithm in comparison with the manual measurement in a large Italian multicentre study in patients with progressive supranuclear palsy.
    Nigro S; Arabia G; Antonini A; Weis L; Marcante A; Tessitore A; Cirillo M; Tedeschi G; Zanigni S; Calandra-Buonaura G; Tonon C; Pezzoli G; Cilia R; Zappia M; Nicoletti A; Cicero CE; Tinazzi M; Tocco P; Cardobi N; Quattrone A
    Eur Radiol; 2017 Jun; 27(6):2665-2675. PubMed ID: 27761709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinicopathological study of vascular progressive supranuclear palsy: a multi-infarct disorder presenting as progressive supranuclear palsy.
    Josephs KA; Ishizawa T; Tsuboi Y; Cookson N; Dickson DW
    Arch Neurol; 2002 Oct; 59(10):1597-601. PubMed ID: 12374498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of Magnetic Resonance Parkinsonism Index in differentiating progressive supranuclear palsy from Parkinson's disease and controls in Indian patients.
    Sankhla CS; Patil KB; Sawant N; Gupta S
    Neurol India; 2016; 64(2):239-45. PubMed ID: 26954800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine learning on brain MRI data for differential diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.
    Salvatore C; Cerasa A; Castiglioni I; Gallivanone F; Augimeri A; Lopez M; Arabia G; Morelli M; Gilardi MC; Quattrone A
    J Neurosci Methods; 2014 Jan; 222():230-7. PubMed ID: 24286700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gradient subthalamic neurodegeneration and tau pathology in the hypoglossal nucleus as essential pathological markers of progressive supranuclear palsy - Richardson syndrome.
    Homma T; Mochizuki Y; Hara M; Kamei S; Mizutani T; Takubo H; Isozaki E; Takahashi M; Komori T; Hao H
    Rev Neurol (Paris); 2020 May; 176(5):353-360. PubMed ID: 32247606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.